In terms of the Companys Code of Conduct to Regulate Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended the trading window for dealing in the shares of Marksans Pharma Limited (the Company) for the designated person(s) of the Company will remain closed from Friday 1st July 2022 till 48 hours after the declaration of unaudited financial results for the quarter ended 30th June 2022. The date of declaration of financial results will be intimated separately in due course of time.Designated Persons of the Company and/or their immediate relatives shall not trade in the shares of the Company during the aforesaid period of closure of trading window.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
